Prof. Dr. İNSU YILMAZ

CHEST , sa.5, 2025 (SCI-Expanded, Scopus)

8. Distinct Characteristics of Asthma Overlap Phenotypes: Insights from the Turkish Adult Asthma Registry.

Kepil Ozdemir S., Gemicioglu B., Yildiz F., Hayme S., Alpagat G., Bozkurt N., et al.

The Journal of asthma : official journal of the Association for the Care of Asthma , ss.1-18, 2025 (SCI-Expanded, Scopus)

9. Factors influencing the prescription of add-on long-acting muscarinic antagonists in real-world asthma management: Insights from a national registry

Gemicioglu B., Gokmen D., Can A., Sevinc C., Oguzulgen I. K., Soyyigit S., et al.

Respiratory Medicine , cilt.236, 2025 (SCI-Expanded, Scopus)

10. Can fluoroquinolones be safely used in patients with immediate hypersensitivity reaction to penicillin?

Acar E., TÜRK M., KÖYLÜCE S., Yilmaz H. E. B., Seker S., Yapici E. A., et al.

ALLERGOLOGIA ET IMMUNOPATHOLOGIA , cilt.53, sa.5, ss.94-99, 2025 (SCI-Expanded, Scopus)

11. Case Report of Systemic Mastocytosis with Cutaneous Involvement

AÇAR E., TÜRK M., YILMAZ İ.

ASTHMA ALLERGY IMMUNOLOGY , cilt.23, sa.1, ss.100-102, 2025 (ESCI, Scopus) Sürdürülebilir Kalkınma

12. Socioeconomic status has direct impact on asthma control: Turkish adult asthma registry

ARSLAN B., TÜRK M., HAYME S., AYDIN Ö., GÖKMEN D., Buhari G. K., et al.

Clinical and Translational Allergy , cilt.15, sa.1, 2025 (SCI-Expanded, Scopus)

13. A New Approach for the Classification of Mechanisms of Chronic Spontaneous Urticaria

ASTHMA ALLERGY IMMUNOLOGY , cilt.23, sa.1, ss.1-2, 2025 (ESCI, Scopus) Sürdürülebilir Kalkınma

14. Asthma patients with obesity have a unique phenotype: a subanalysis of the Turkish adult asthma registry

ÇELEBİ SÖZENER Z., OĞUZÜLGEN İ. K., Ozalp Ates F. S., Baccioglu A., ARGUN BARIŞ S., EDİGER D., et al.

Journal of Asthma , cilt.62, sa.7, ss.1183-1194, 2025 (SCI-Expanded, Scopus)

15. Mepolizumab: Which condition benefits more: Nasal polyps or eosinophilic asthma? Mepolizumab: Hangi durum daha fazla fayda sağlar: Burun polipleri mi, eozinofilik astım mı?

AÇAR E., KÖYLÜCE S., ŞEKER S., BOZKURT YILMAZ H. E., AKTAŞ YAPICI E., ARSLAN B., et al.

Tuberkuloz ve Toraks , cilt.73, sa.1, ss.52-59, 2025 (ESCI, Scopus, TRDizin)

16. Trends in prescribing montelukast in patients with asthma in real-life: Results from the Turkish adult asthma registry

Beyaz S., Erdinc M., HAYME S., ASLAN A. F., Aydin O., Gokmen D., et al.

ALLERGOLOGIA ET IMMUNOPATHOLOGIA , cilt.53, sa.1, ss.12-25, 2025 (SCI-Expanded, Scopus)

17. GINA step 1-2 therapy: Low-dose ICSformoterol combination taken as needed or moderate-dose ICS-formoterol combination taken as needed?

PAÇACI ÇETİN G., ARSLAN B., YILMAZ İ.

Tüberküloz ve Toraks , cilt.72, sa.4, ss.316-317, 2024 (ESCI, Scopus, TRDizin)

18. Turkish Severe Asthma Program (TSAP)

BAVBEK S., soyer ö., DİBEK MISIRLIOĞLU E., BAÇÇIOĞLU A., CAN D., KALPAKLIOĞLU A. F., et al.

ASTIM ALLERJI IMMUNOLOJI , cilt.22, sa.3, ss.339-350, 2024 (ESCI, Scopus)

19. What should be the outcome of biologic treatment in asthma: " remission on treatment " or " super-responder "

Cetin G. P., YILMAZ İ.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY , cilt.133, sa.1, ss.11-12, 2024 (SCI-Expanded, Scopus)

20. The definition of remission in asthma should be unique and specific

Yilmaz I., ÇETİN g., Türk M.

Tüberküloz ve Toraks , cilt.72, sa.2, ss.176-178, 2024 (ESCI, Scopus, TRDizin)

21. The Effectiveness of Biological Agents on Chronic Rhinosinusitis with Nasal Polyposis in Patients with Comorbid Asthma: A Multicenter Real-Life Study from Türkiye

Demir M., TUNAKAN DALGIÇ C., METE GÖKMEN E. N., SAVAŞ R., EROĞLU S., Ozden G., et al.

MEDICINA-LITHUANIA , cilt.60, sa.3, 2024 (SCI-Expanded, Scopus)

22. Patient-Reported Outcomes in Assessing Disease Activity, Control, and Quality of Life in Chronic Spontaneous Urticaria

BEYHAN N., TÜRK M., YILMAZ İ., BAVBEK S.

ASTHMA ALLERGY IMMUNOLOGY , cilt.22, ss.217-224, 2024 (ESCI, Scopus)

23. Characteristics of asthma in an older adult population according to sex and control level: why are asthma symptoms in older women not well-controlled?

KARADOĞAN D., YILMAZEL UÇAR E., YAVUZ Y., BAÇÇIOĞLU A., Oeztuerk A. B., Bozkurt N., et al.

JOURNAL OF ASTHMA , cilt.61, sa.6, ss.539-549, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

24. Capsaicin Pretreatment Increases Mast Cell-Mediated But Not Histamine-Induced Wheal and Erythema Responses: A Proof-of-Concept Study

TÜRK M., YILMAZ İ., Bahcecioglu S. N., PAÇACI ÇETİN G., Elieh-Ali-Komi D., Maurer M.

ASTHMA ALLERGY IMMUNOLOGY , cilt.22, sa.1, ss.49-57, 2024 (ESCI, Scopus, TRDizin)

25. Doxycycline may be more clinically effective in type 2 chronic rhinosinusitis nasal polyp comorbid with asthma

JOURNAL OF ASTHMA , cilt.61, sa.1, ss.20-26, 2024 (SCI-Expanded, Scopus)

26. Capsaicin Pretreatment Increases Mast Cell-Mediated But Not Histamine-Induced Wheal and Erythema Responses: A Proof-of-Concept Study

TÜRK M., YILMAZ İ., NAZİK BAHÇECİOĞLU S., PAÇACI ÇETİN G., Elieh-ali-komi D., Maurer M.

ASTHMA ALLERGY IMMUNOLOGY , 2023 (ESCI)

27. Stepwise Approach in Asthma Revisited 2023: Expert Panel Opinion of Turkish Guideline of Asthma Diagnosis and Management Group

ÇELİK G. E., AYDIN Ö., DAMADOĞLU E., Baççıoğlu A., Özdemir S. K., BAVBEK S., et al.

Thoracic Research and Practice , cilt.24, sa.6, ss.309-324, 2023 (ESCI, Scopus, TRDizin)

28. Omalizumab in severe asthma with seasonal allergic sensitization

Tuerk M., Tutar N., Yilmaz I.

REVUE FRANCAISE D'ALLERGOLOGIE , cilt.63, sa.5, ss.103675, 2023 (SCI-Expanded, Scopus)

29. The Role of Long-Acting Antimuscarinic Agents in the Treatment of Asthma

ARSLAN B., PAÇACI ÇETİN G., YILMAZ İ.

JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY , cilt.36, sa.4, ss.189-209, 2023 (SCI-Expanded, Scopus)

30. Usage of biomarkers in the treatment of chronic spon- taneous urticaria

Yilmaz H. E. B., Cetin G. P., YILMAZ İ.

REVUE FRANCAISE D ALLERGOLOGIE , cilt.63, sa.4, 2023 (SCI-Expanded, Scopus)

31. Can clarithromycin be used without testing in patients with penicillin allergy?

Arslan B., Cetin G. P., YILMAZ İ.

REVUE FRANCAISE D ALLERGOLOGIE , cilt.63, sa.4, 2023 (SCI-Expanded, Scopus)

32. Biological therapy management from the initial selection of biologics to switching between biologics in severe asthma

YILMAZ İ., ÇETİN G. P., ARSLAN B., ŞEKER S., YILMAZ H. E. B., AKTAŞ E., et al.

Tüberküloz ve Toraks , cilt.71, sa.1, ss.75-93, 2023 (ESCI, Scopus, TRDizin)

33. Physical activity and dietary habits in patients with asthma: How is it related to asthma control?

AYDIN Ö., Çelebi Sözener Z., MUNGAN V. D., Özbey Ü., BALABAN S., GÖKMEN D., et al.

Obesity Medicine , cilt.38, 2023 (Scopus)

34. Biologics for the treatment of severe asthma: Current status report 2023 Ağır astım tedavisinde biyolojikler: Güncel durum raporu 2023

PAÇACI ÇETİN G., Kepil Özdemir S., Can Bostan Ö., Öztop N., Çelebi Sözener Z., KARAKAYA G., et al.

Tuberkuloz ve Toraks , cilt.71, sa.2, ss.176-187, 2023 (ESCI, Scopus, TRDizin)

35. Evaluation of diaphragm functions with diaphragm ultrasound and pulmonary function tests in individuals with Friedreich?s ataxia

YETKİN N. A., YETKİN M. F., BARAN B., OYMAK F. S., GÜLMEZ İ., YILMAZ İ., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.53, sa.5, ss.1301-1311, 2023 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

36. Picturing asthma in Turkey: results from the Turkish adult asthma registry

Celik G. E., Aydin O., Gokmen D., Buhari G. K., Sozener Z. C., Gemicioglu B., et al.

JOURNAL OF ASTHMA , cilt.60, sa.11, ss.1973-1986, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

37. Assessment of CD63 and CD203c Basophil Activation Tests in Patients with Immediate Drug Hypersensitivity Reaction to Rocuronium

Doğruel F., Günay Canpolat D., Özsoy S., Rıhtım T., Köker M. Y., Yılmaz İ.

ERCIYES MEDICAL JOURNAL , cilt.45, sa.1, ss.25-31, 2023 (ESCI, TRDizin)

38. Discontinuing Omalizumab Treatment in Super-Responder Patients with Allergic Severe Asthma: Can the Baseline Total IgE Level Be Used as a Biological Marker to Decide Discontinuing Omalizumab Treatment?

ARSLAN B., PAÇACI ÇETİN G., Turk M., GÜLMEZ İ., YILMAZ İ.

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY , cilt.183, sa.10, ss.1071-1077, 2022 (SCI-Expanded, Scopus)

39. The External Exposome and Allergies: From the Perspective of the Epithelial Barrier Hypothesis

Sozener Z. C., Yucel U. O., ALTINER S., Ozturk B. O., Cerci P., Turk M., et al.

FRONTIERS IN ALLERGY , cilt.3, 2022 (ESCI)

40. Anti-IL5/IL5R switching between biologics in patients with severe eosinophilic asthma

YILMAZ İ., Çetin G. P., ARSLAN B.

Journal of Allergy and Clinical Immunology: In Practice , cilt.10, sa.7, ss.1935-1936, 2022 (SCI-Expanded, Scopus)

41. Epithelial barrier hypothesis: Effect of external exposome on microbiome and epithelial barriers in allergic disease

Sozener Z. C., Ozturk B. O., Cerci P., Turk M., Akin B. G., Akdis M., et al.

ALLERGY , cilt.77, sa.5, ss.1418-1449, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

42. Experience-based advice on stepping up and stepping down the therapeutic management of chronic spontaneous urticaria: Where is the guidance?

Turk M., YILMAZ İ., ŞAHİNER Ü. M., Kocaturk E., ŞEKEREL B. E., Zuberbier T., et al.

ALLERGY , cilt.77, ss.1626-1630, 2022 (SCI-Expanded, Scopus)

43. Mepolizumab-Related Adverse Events in Severe Eosinophilic Asthma: A Real-Life Study

NAZİK BAHÇECİOĞLU S., TURK M., ATAYIK E., PAÇACI ÇETİN G., ARSLAN B., GÜLMEZ İ., et al.

ASTIM ALLERJI IMMUNOLOJI , cilt.20, sa.2, ss.81-86, 2022 (ESCI, Scopus, TRDizin)

44. Safety Profiles of Biological Therapies Used in Asthma Treatment

PAÇACI ÇETİN G., ARSLAN B., YILMAZ İ.

ASTIM ALLERJI IMMUNOLOJI , cilt.20, sa.3, ss.127-141, 2022 (ESCI, Scopus, TRDizin)

45. Stable and exacerbation period serum cytokine and periostin levels of the five distinct phenotypes of severe asthma

TÜRK M., YILMAZ İ., GÖKAHMETOĞLU S., KOÇ A. N.

Turkish Journal of Medical Sciences , cilt.52, sa.4, ss.1148-1159, 2022 (SCI-Expanded, Scopus, TRDizin)

46. The Management of Acute and Chronic Urticaria

YILMAZ İ., PAÇACI ÇETİN G., ARSLAN B., Turk M.

ASTIM ALLERJI IMMUNOLOJI , cilt.20, sa.3, ss.202-204, 2022 (ESCI, Scopus, TRDizin)

47. Editor's Preface

Yilmaz İ.

ASTIM ALLERJI IMMUNOLOJI , sa.1, 2022 (ESCI, Scopus)

48. Classification of asthma severity: Severe/not severe asthma or mild/moderate/severe asthma?

YILMAZ İ., Cetin G. P., ARSLAN B.

TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX , cilt.70, sa.3, ss.300-301, 2022 (ESCI, Scopus, TRDizin)

49. The adequacy of current diagnostic criteria for making a diagnosis of ABPA

Bahcecioglu S. N., Turk M., PAÇACI ÇETİN G., YILMAZ İ.

TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX , cilt.70, sa.2, ss.141-148, 2022 (ESCI, Scopus, TRDizin)

50. Venom immunotherapy and difficulties encountered before and during immunotherapy: Double sensitization, systemic reactions, treatment with omalizumab, and high dose VIT

PAÇACI ÇETİN G., YILMAZ İ., Turk M., ARSLAN B., Bahcecioglu S. N.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.52, sa.4, ss.1223-1234, 2022 (SCI-Expanded, Scopus, TRDizin)

51. Are we entering an era of combined biologic use for severe asthma?

ARSLAN B., ŞEKER S., YILMAZ İ.

Tuberkuloz ve Toraks , cilt.70, sa.4, ss.403-404, 2022 (ESCI, Scopus, TRDizin)

52. A case of hypersensitivity developing against trace element solution in total parenteral nutrition, proved by skin prick test

PAÇACI ÇETİN G., Turk M., Bahcecioglu S. N., YILMAZ İ.

EUROPEAN JOURNAL OF CLINICAL NUTRITION , cilt.75, sa.12, ss.1829-1831, 2021 (SCI-Expanded, Scopus)

53. Stable and exacerbation period serum cytokine and periostin levels of the five distinct phenotypes of severe asthma.

Türk M., Yilmaz İ., Gökahmetoğlu S., Koç A. N.

Turkish journal of medical sciences , 2021 (SCI-Expanded, Scopus, TRDizin)

54. Current approach to the diagnosis of allergic bronchopulmonary aspergillosis

Turk M., NAZİK BAHÇECİOĞLU S., YILMAZ İ.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE , cilt.9, sa.6, ss.2546, 2021 (SCI-Expanded, Scopus)

55. The Visible and Invisible Faces of the Iceberg of Type 2 Asthma

YILMAZ İ., PAÇACI ÇETİN G.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE , cilt.203, sa.11, ss.1443-1444, 2021 (SCI-Expanded, Scopus)

56. High-Dose Omalizumab versus Ligelizumab for the Treatment of Chronic Spontaneous Urticaria: Do Not We Need a Head-To-Head Comparison?

Turk M., YILMAZ İ.

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY , cilt.182, sa.5, ss.461-462, 2021 (SCI-Expanded, Scopus)

57. Worsening of chronic spontaneous urticaria after intake of hot pepper

TÜRK M., YILMAZ İ., Hawro T., Maurer M.

ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY , cilt.39, sa.1, ss.25-30, 2021 (SCI-Expanded, Scopus)

58. Blood hyperreosinophilia: A diagnostic challenge

PAÇACI ÇETİN G., KÖSE M., ARSLAN B., YILMAZ İ.

TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX , cilt.69, sa.3, ss.408-415, 2021 (ESCI, Scopus, TRDizin)

59. Effectiveness of mepolizumab therapy on symptoms, asthma exacerbations, steroid dependence, and small airways in patients with severe eosinophilic asthma

YILMAZ İ., Nazik Bahcecioglu S., Turk M., TUTAR N., PAÇACI ÇETİN G., ARSLAN B.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.51, sa.4, ss.1953-1959, 2021 (SCI-Expanded, Scopus, TRDizin)

60. Long-term macrolide therapy in asthma

PAÇACI ÇETİN G., Arslan B., YILMAZ İ.

TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX , cilt.69, sa.4, ss.520-534, 2021 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

61. Effectiveness of as-needed antihistamines in chronic spontaneous urticaria patients under omalizumab treatment

TÜRK M., YILMAZ İ., NAZİK BAHÇECİOĞLU S., Can P., Ertas R., KARTAL D., et al.

DERMATOLOGIC THERAPY , cilt.34, sa.1, 2021 (SCI-Expanded, Scopus)

62. A prospective observational evaluation of treatment outcomes of patients with chronic obstructive pulmonary disease and peripheral blood eosinophilia Kronik obstrüktif akciğer hastalığı ve periferik kan eozinofilisi olan hastaların tedavi sonuçlarının prospektif gözlemsel değerlendirilmesi

Tutar N., Arslantaş F., Baran Ketencioğlu B., Yılmaz İ., Oymak F. S., Gülmez İ.

Tuberkuloz ve Toraks , cilt.69, sa.4, ss.477-485, 2021 (ESCI, Scopus, TRDizin)

63. Frequency of peripheral blood eosinophilia and obstructive airway disease in sarcoidosis

Rabahoglu B., OYMAK F. S., Ketencioglu B. B., TUTAR N., GÜLMEZ İ., YILMAZ İ.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.51, sa.6, ss.3001-3007, 2021 (SCI-Expanded, Scopus, TRDizin)

64. Asthma phenotype and endotype definitions

YILMAZ İ., PAÇACI ÇETİN G.

TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX , cilt.69, sa.2, ss.288-290, 2021 (ESCI, Scopus, TRDizin)

65. Type 2 inflammation in asthma

YILMAZ İ., ARSLAN B.

TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX , cilt.69, sa.1, ss.114-115, 2021 (ESCI, Scopus, TRDizin)

66. Type 2 chronic rhinosinusitis with nasal polyps: From phenotype to endotype

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE , cilt.9, sa.1, ss.600-601, 2021 (SCI-Expanded, Scopus)

67. Careful Selection of Patients Is Required to Obtain Higher Potential Benefit From Mepolizumab Therapy

CHEST , cilt.158, sa.5, ss.2229-2230, 2020 (SCI-Expanded, Scopus)

68. Non-Infectious Diseases Compatible With COVID-19 Pneumonia

BARAN KETENCİOĞLU B., YİĞİT F., Almadqa M., TUTAR N., YILMAZ İ.

CUREUS , cilt.12, sa.8, 2020 (ESCI) Sürdürülebilir Kalkınma

69. Biologics for oral corticosteroid-dependent asthma

ALLERGY AND ASTHMA PROCEEDINGS , cilt.41, sa.3, ss.151-157, 2020 (SCI-Expanded, Scopus)

70. The protective effects of thymoquinone on lung damage caused by cigarette smoke

Yetkin N. A., Buyukoglan H., Sonmez M. F., TUTAR N., GÜLMEZ İ., YILMAZ İ.

BIOTECHNIC & HISTOCHEMISTRY , cilt.95, sa.4, ss.268-275, 2020 (SCI-Expanded, Scopus)

71. The presence of underlying asthma should be investigated in patients diagnosed with ACE inhibitor induced cough

Yilmaz İ., Türk M., Baran K., Çetinkaya Z., Tutar N., Oymak F. S., et al.

Clinical Respiratory Journal , cilt.14, sa.4, ss.382-388, 2020 (SCI-Expanded, Scopus)

72. Efficacy of mepolizumab treatment in oral corticosteroid-dependent severe eosinophilic asthma patients with chronic rhinosinusitis with nasal polyps: single center, real life study

YILMAZ İ., TÜRK M., NAZİK BAHÇECİOĞLU S., TUTAR N., GÜLMEZ İ.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.50, sa.2, ss.433-441, 2020 (SCI-Expanded, Scopus, TRDizin)

73. What Should the Optimal Adrenaline Auto-Injector Needle Length Be?

TÜRK M., Turk G., KOÇ A., KARABIYIK Ö., YILMAZ İ.

ASTIM ALLERJI IMMUNOLOJI , cilt.18, sa.2, ss.82-90, 2020 (ESCI, TRDizin)

74. Horse allergen sensitivity and respiratory symptoms among horse farm workers

Baran Ketencioğlu B., Yilmaz İ., Tutar N., Gülmez İ., Oymak F. S.

Turkish Journal of Medical Sciences , cilt.50, sa.4, ss.910-916, 2020 (SCI-Expanded, Scopus, TRDizin)

75. Selection of Biologics for Type 2-High Asthma

PAÇACI ÇETİN G., Yilmaz H. E. B., YILMAZ İ.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE , cilt.200, sa.6, ss.790-791, 2019 (SCI-Expanded, Scopus)

76. How to discontinue omalizumab in chronic spontaneous urticaria?

TÜRK M., Maurer M., YILMAZ İ.

ALLERGY , cilt.74, sa.4, ss.821-824, 2019 (SCI-Expanded, Scopus)

77. Should There be a Washout Period When Switching to Another Biological in Asthma?

ASTIM ALLERJI IMMUNOLOJI , cilt.17, sa.1, ss.25-27, 2019 (ESCI, Scopus, TRDizin)

78. Urticaria control test might misevaluate disease control in particular patients treated with omalizumab

TÜRK M., YILMAZ İ.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY , cilt.122, sa.3, ss.342-343, 2019 (SCI-Expanded, Scopus)

79. Last station in the eosinophilic asthma with chronic rhinosinusitis and/or nasal polyposis march: Eosinophilic asthma with radiological findings associated with blood eosinophilia

YILMAZ İ., Bahcecioglu S. N., TÜRK M., TUTAR N., OYMAK F. S., GÜLMEZ İ.

JOURNAL OF ASTHMA , cilt.56, sa.2, ss.111-117, 2019 (SCI-Expanded, Scopus)

80. Angiotensin-Converting Enzyme Inhibitors Induce Cough

Turkish Thoracic Journal , cilt.20, sa.1, ss.36-42, 2019 (ESCI, Scopus, TRDizin)

81. Selection of Biologics for Severe Type-2 Asthma

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY , cilt.29, sa.5, ss.399-400, 2019 (SCI-Expanded, Scopus)

82. Eosinophilic asthma with chronic rhinosinusitis/nasal polyps and biologic agents

TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX , cilt.67, sa.4, ss.292-299, 2019 (ESCI, Scopus, TRDizin)

83. A Rare Case of Multiple Severe Anaphylaxis Caused by Thyme, Black Pepper, Wasp and Honey

TÜRK M., YILMAZ İ.

ASTIM ALLERJI IMMUNOLOJI , cilt.17, sa.2, ss.115-117, 2019 (ESCI, TRDizin)

84. What should the ideal adrenaline auto-injector needle length be?

Turk M., Turk G., Koc A., Karabiyik O., Yilmaz İ.

ASTIM ALLERJI IMMUNOLOJI , cilt.0, sa.0, 2019 (TRDizin)

85. Omalizumab Treatment for Atopic Severe Persistant Asthma: A Single-Center, Long-Term, Real-Life Experience with 38 Patients

TÜRK M., NAZİK BAHÇECİOĞLU S., TUTAR N., OYMAK F. S., GÜLMEZ İ., YILMAZ İ.

Turkish Thoracic Journal , cilt.19, sa.4, ss.187-192, 2018 (Scopus, TRDizin)

86. Confusing Terminology: Difficult Asthma, Difficult-to-Treat Asthma, Difficult-to-Control Asthma, Therapy-Resistant Asthma, Severe Asthma, and Refractory Asthma. Which One is Truly Severe Asthma?

Turkish Thoracic Journal , cilt.19, sa.4, ss.235-236, 2018 (Scopus, TRDizin)

87. ATOPIK DERMATIT TANI VE TEDAVISINEYAKLAŞIM: ULUSAL REHBER 2018veÜRTIKER TANI VE TEDAVISIGÜNCEL DURUM RAPORU

AKSU K., ARGA M., ASİLSOY S., Avcıl S., Çetinkaya F., CİVELEK E., et al.

Astım Allerji İmmünoloji , cilt.16, sa.2, 2018 (TRDizin)

88. Two-week intervals during omalizumab treatment may provide better symptom control in selected patients with chronic urticaria

Turk M., Kocaturk E., Cure K., YILMAZ İ.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE , cilt.6, sa.4, ss.1389-1390, 2018 (SCI-Expanded, Scopus)

89. Biologic Targeted Therapies for the Phenotypes of Type-2 High Severe Asthma

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE , cilt.6, sa.3, ss.1091-1092, 2018 (SCI-Expanded, Scopus)

90. Comparison of the effects of intravenous Dexketoprofen Trometamol versus Paracetamol on postoperative analgesia in patients undergoing Septoplasty: A randomised double-blind clinical trial

Caliskan E., Sener M., Kipri M., YILMAZ İ., Aribogan A.

PAKISTAN JOURNAL OF MEDICAL SCIENCES , cilt.34, sa.3, ss.546-552, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

91. Is Asthma-COPD overlap an asthma phenotype or a COPD phenotype?

Turk M., YILMAZ İ., Bahcecioglu S. N.

Tuberkuloz ve Toraks , cilt.66, sa.1, ss.78-79, 2018 (Scopus, TRDizin)

92. ATOPİK DERMATİT TANI VE TEDAVİSİNE YAKLAŞIM

AKSU K., ARGA M., ASİLSOY S., AVCİL S., ÇETİNKAYA F., CİVELEK E., et al.

Astım Allerji İmmunoloji , 2018 (TRDizin)

93. Treatment and retreatment with omalizumab in chronic spontaneous urticaria: Real life experience with twenty-five patients

ALLERGOLOGY INTERNATIONAL , cilt.67, sa.1, ss.85-89, 2018 (SCI-Expanded, Scopus)

94. Local anesthetics allergy: who should be tested

YILMAZ İ., KEPİL ÖZDEMİR S., AYDIN Ö., ÇELİK G. E.

European Annals of Allergy and Clinical Immunology , 2018 (Scopus)

95. Combination of omalizumab and bee venom immunotherapy: does it work?

YILMAZ İ., NAZİK BAHÇECİOĞLU S., TÜRK M.

Asia Pacific Allergy , cilt.8, sa.1, ss.2, 2018 (ESCI)

96. Comment on: "Targeting the PGD(2)/CRTH2/DP1 Signaling Pathway in Asthma and Allergic Disease: Current Status and Future Perspectives"

YILMAZ İ., Turk M., Bahcecioglu S. N.

DRUGS , cilt.77, sa.17, ss.1925-1926, 2017 (SCI-Expanded, Scopus)

97. Eosinophilic asthma with nasal polyposis march: Is aspirin-exacerbated respiratory disease the last station?

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE , cilt.5, sa.6, ss.1807-1808, 2017 (SCI-Expanded, Scopus)

98. What Should Be the Cutoff Value of Blood Eosinophilia as a Predictor of Inhaled Corticosteroid Responsiveness in Patients with Chronic Obstructive Pulmonary Disease?

YILMAZ İ., TÜRK M., NAZİK BAHÇECİOĞLU S.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE , cilt.196, sa.9, ss.1229-1230, 2017 (SCI-Expanded, Scopus)

99. Successful rapid subcutaneous desensitization to anakinra in a case with a severe immediate-type hypersensitivity reaction

European Annals of Allergy and Clinical Immunology , cilt.50, sa.2, ss.94, 2017 (Scopus)

100. Asthma management: A new phenotype-based approach using presence of eosinophilia and allergy

YILMAZ İ., Turk M., Bahcecioglu S. N.

ALLERGY , cilt.72, sa.10, ss.1587-1588, 2017 (SCI-Expanded, Scopus)

101. Classification of eosinophilic granulomatosis with polyangiitis phenotypes and treatment based on phenotypes

AUTOIMMUNITY REVIEWS , cilt.16, sa.9, ss.992-993, 2017 (SCI-Expanded, Scopus)

102. Clinical and Serological Features of Eosinophilic and Vasculitic Phases of Eosinophilic Granulomatosis with Poliangiitis: a Case Series of 15 Patients

Yilmaz I., TUTAR N., Simsek Z. O., OYMAK F. S., GÜLMEZ I.

TURKISH THORACIC JOURNAL , cilt.18, sa.3, ss.72-77, 2017 (ESCI, Scopus)

103. Is nonhomogeneous expression of tissue mast cells or allergen specific IgEs bound to tissue mast cells possible?

Turk M., Bahcecioglu S. N., YILMAZ İ.

ASIA PACIFIC ALLERGY , cilt.7, sa.3, ss.179-181, 2017 (ESCI)

104. Successful Desensitization in a Patient with Hypersensitivity Reaction to Laronidase

YILMAZ İ., SEZGİN ÇAĞLAR A., KARDAŞ F., ÖZDAMAR KARACA Z. C., YENİGÜN S., TUTAR N.

Pediatric Allergy Immunology And Pulmonology , cilt.30, ss.64-66, 2017 (SCI-Expanded, Scopus)

105. A Baker with Asthma and Wheat Flour Food Allergy

Yilmaz I., Mungan D.

ASTIM ALLERJI IMMUNOLOJI , cilt.15, sa.2, ss.107-110, 2017 (ESCI, TRDizin)

106. Tenoxicam-Induced Fixed Drug Eruption Confirmed by Skin Patch Test

Yilmaz I., TUTAR N., Yenigun S., Simsek Z. O., GÜLMEZ I.

ASTIM ALLERJI IMMUNOLOJI , cilt.15, sa.3, ss.162-164, 2017 (ESCI, TRDizin)

107. Comment on: “Targeting the PGD2/CRTH2/DP1 Signaling Pathway in Asthma and Allergic Disease: Current Status and Future Perspectives”

Drugs , cilt.77, ss.925-1926, 2017 (SCI-Expanded, Scopus)

108. Ranitidine-Induced Anaphylaxis in a Patient with Acute COPD Exacerbation

TURKISH THORACIC JOURNAL , cilt.18, ss.94-95, 2017 (ESCI, Scopus, TRDizin)

109. The Association of Brain-Derived Neurotrophic Factor Gene Polymorphism with Obstructive Sleep Apnea Syndrome and Obesity

Yuksekkaya M., TUTAR N., Buyukoglan H., DÜNDAR M., YILMAZ I., GÜLMEZ I., et al.

LUNG , cilt.194, sa.5, ss.839-846, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

110. Evaluation of drug provocation teste-related anxiety in patients with drug hypersensitivity

Soyyigit S., Aydin O., Yilmaz I., Ozdemir S. K., Cankorur V. S., Atbasoglu C., et al.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY , cilt.117, sa.3, ss.280-284, 2016 (SCI-Expanded, Scopus)

111. Response of Complex Undefined Hypereosinophilic Syndrome to Treatment with Imatinib

Yilmaz I., KAYNAR L., TUTAR N., PALA C., CANÖZ Ö., Yıldırım A., et al.

TURKISH THORACIC JOURNAL , cilt.17, sa.3, ss.118-121, 2016 (ESCI)

112. Turkish version of the Drug Hypersensitivity Quality of Life Questionnaire: assessment of reliability and validity

Bavbek S., Ozdemir S. K., Erdogan B. D., Karaboga I., Buyukozturk S., Gelincik A., et al.

QUALITY OF LIFE RESEARCH , cilt.25, sa.1, ss.101-109, 2016 (SCI-Expanded, SSCI, Scopus)

113. Response to imatinib in patient with corticosteroid-unresponsive idiopatic hypereosinophilic syndrome

Yilmaz I., KAYNAR L., TUTAR N., PALA Ç., CANÖZ Ö., Buyukoglan H., et al.

REVISTA PORTUGUESA DE PNEUMOLOGIA , cilt.22, sa.1, ss.59-60, 2016 (SCI-Expanded)

114. Evaluation of vascular endothelial growth factor-A and Endostatin levels in induced sputum and relationship to bronchial hyperreactivity in patients with persistent allergic rhinitis monosensitized to house dust

Yilmaz İ., Bayraktar N., Ceyhan K., Secil D., Yuksel S., Misirligil Z., et al.

REVISTA PORTUGUESA DE PNEUMOLOGIA , cilt.21, sa.6, ss.321-326, 2015 (SCI-Expanded, Scopus)

115. İlaç Reaksiyonlarında Altta Yatan Mekanizmalar

Karacan Ö., YILMAZ İ., Eyüboǧlu F. Ö.

Türkiye Klinikleri İmmünoloji Allerji Özel Dergisi , 2015 (Hakemli Dergi)

116. Is Serum Cystatin C a Predictor of Acute Pulmonary Thromboembolism in Patients With Normal Renal Function?

TUTAR N., KEMIK N. A., YILMAZ I., Buyukoglan H., KANBAY A., DOĞAN A., et al.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , cilt.21, sa.6, ss.533-538, 2015 (SCI-Expanded, Scopus)

117. Response of complex undefined hypereosinophilic syndrome to treatment with imatinib Churg Strauss syndrome in the differantial diagnosis

YILMAZ İ., KAYNAR L., TUTAR N., PALA Ç., CANÖZ Ö., BÜYÜKOĞLAN H., et al.

Allergy , cilt.70, ss.396, 2015 (SCI-Expanded, Scopus)

118. Churg-Strauss syndrome: a new endotype of severe asthma? Results of 14 Turkish patients

Yilmaz I., Celik G., Aydin O., Ozdemir S. K., Soyyigit S., Sozener Z., et al.

CLINICAL RESPIRATORY JOURNAL , cilt.9, sa.3, ss.350-358, 2015 (SCI-Expanded, Scopus)

119. Drug allergy in tertiary care in Turkey: Results of a national survey. The ADAPT study: Adult drug allergy perception in Turkey

Celik G. E., KARAKAYA G., ÖZTÜRK A. B., Gelincik A., Abadoglu O., SİN A. Z., et al.

ALLERGOLOGIA ET IMMUNOPATHOLOGIA , cilt.42, sa.6, ss.573-579, 2014 (SCI-Expanded, Scopus)

120. Is serum cystatin C a predictor of acute pulmonary thromboembolism in patients with normal renal function?

Tutar N., Kemik N. A., Yilmaz İ., YAZICI C., Elmali F., Buyukoglan H., et al.

EUROPEAN RESPIRATORY JOURNAL , cilt.44, 2014 (SCI-Expanded, Scopus)

121. Sensitization to pets in pet shop workers Reply

Yilmaz I., ERKEKOL F. O., Secil D., Misirligil Z., Mungan D.

OCCUPATIONAL MEDICINE-OXFORD , cilt.64, sa.6, ss.471, 2014 (SCI-Expanded, Scopus)

122. How do patients with asthma and COPD behave during fasting?

Aydin O., Celik G. E., Onen Z. P., Yilmaz I., Ozdemir S. K., Yildiz O., et al.

ALLERGOLOGIA ET IMMUNOPATHOLOGIA , cilt.42, sa.2, ss.115-119, 2014 (SCI-Expanded, Scopus)

123. Learning curve of conventional transbronchial needle aspiration

TUTAR N., Buyukoglan H., YILMAZ I., KANBAY A., ÖNAL Ö., BİLGİN M., et al.

CLINICAL RESPIRATORY JOURNAL , cilt.8, sa.1, ss.79-85, 2014 (SCI-Expanded, Scopus)

124. Peripartum genital tuberculosis presenting with ascites

Dogan S., Celikbilek M., Topaloglu U. S., CANÖZ Ö., YILMAZ İ., Yurci A., et al.

Clinical Journal of Gastroenterology , cilt.7, sa.1, ss.27-31, 2014 (Scopus) Sürdürülebilir Kalkınma

125. Non-Asbestos-related Malignant Pleural Mesothelioma

KANBAY A., SIMSEK Z. O., TUTAR N., YILMAZ I., Buyukoglan H., CANÖZ Ö., et al.

INTERNAL MEDICINE , cilt.53, sa.17, ss.1977-1979, 2014 (SCI-Expanded, Scopus)

126. The role of extracellular matrix in lung diseases

Derya M., YILMAZ I., Aytekin M.

European Journal of Physical and Health Education , cilt.6, sa.2, 2014 (Scopus)

127. Cat and dog sensitization in pet shop workers

Yilmaz I., ERKEKOL F. O., Secil D., Misirligil Z., Mungan D.

OCCUPATIONAL MEDICINE-OXFORD , cilt.63, sa.8, ss.563-567, 2013 (SCI-Expanded, Scopus)

128. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease

TUTAR N., Metan G., Koc A. N., YILMAZ I., Bozkurt I., SIMSEK Z. O., et al.

MULTIDISCIPLINARY RESPIRATORY MEDICINE , cilt.8, 2013 (SCI-Expanded, Scopus)

129. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary diseases

TUTAR N., Metan G., KOÇ A. N., YILMAZ İ., Bozkurt I., Simsek Z. O., et al.

EUROPEAN RESPIRATORY JOURNAL , cilt.42, 2013 (SCI-Expanded, Scopus)

130. Immediate-type hypersensitivity reactions to proton pump inhibitors: usefulness of skin tests in the diagnosis and assessment of cross-reactivity

Ozdemir S. K., Yilmaz I., Aydin O., Buyukozturk S., Gelincik A., Demirtürk M. O., et al.

ALLERGY , cilt.68, sa.8, ss.1008-1014, 2013 (SCI-Expanded, Scopus)

131. Coexistence of allergic bronchopulmonary aspergillosis and atopic dermatitis: Is total IgE level useful to identify relapses of allergic bronchopulmonary aspergillosis?

Yilmaz I., Aydin O., Ozdemir S. K., Mungan D., Celik G.

ALLERGOLOGIA ET IMMUNOPATHOLOGIA , cilt.41, sa.4, ss.281-283, 2013 (SCI-Expanded, Scopus)

132. Does drug compliance change in asthmatic patients during pregnancy?

Yilmaz I., ERKEKOL F. O., CELEN S., KARACA M. Z., Aydin O., Celik G., et al.

MULTIDISCIPLINARY RESPIRATORY MEDICINE , cilt.8, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

133. Evaluation of vascular endothelial growth factor A and endostatin levels in induced sputum and relationship to bronchial hyperreactivity in patients with seasonal allergic rhinitis

Yilmaz I., Bayraktar N., Ceyhan K., Secil D., Yuksel S., Misirligil Z., et al.

AMERICAN JOURNAL OF RHINOLOGY & ALLERGY , cilt.27, sa.3, ss.181-186, 2013 (SCI-Expanded, Scopus)

134. Fixed drug eruption caused by ornidazole and fluconazole but not isoconazole, itraconazole, ketoconazole and metronidazole

Bavbek S., Yilmaz I., Sozener Z. C.

JOURNAL OF DERMATOLOGY , cilt.40, sa.2, ss.134-135, 2013 (SCI-Expanded, Scopus)

135. Lung abscess: analysis of the results as community-acquired or nosocomial

TUTAR N., OYMAK F. S., Kanbay A., Buyukoglan H., YILDIRIM A., YILMAZ I., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.43, sa.2, ss.255-262, 2013 (SCI-Expanded, Scopus, TRDizin)

136. [Strongyloides stercoralis hyperinfection syndrome in a patient with Behçet's Disease]. Behçet Hastasinda Strongyloides stercoralis Hiperenfeksiyon Sendromu.

YILMAZ İ., Caǧlar B., Akay B. N., Alkiz G., Boyvat A., Akyol A.

Türkiye parazitolojii dergisi / Türkiye Parazitoloji Derneǧi = Acta parasitologica Turcica / Turkish Society for Parasitology , cilt.37, sa.2, ss.139-142, 2013 (Scopus, TRDizin)

137. A most common type of occupational asthma: baker's asthma

YILMAZ İ., Mungan D.

ASTIM ALLERJI IMMUNOLOJI , sa.3, ss.139-145, 2013 (ESCI, TRDizin) Sürdürülebilir Kalkınma

138. Triggers of asthma and COPD: Are they different?

Aydin O., Celik G. E., Onen Z. P., Yilmaz I., Ozdemir S. K., Yildiz O., et al.

ALLERGOLOGIA ET IMMUNOPATHOLOGIA , cilt.41, sa.1, ss.30-36, 2013 (SCI-Expanded, Scopus)

139. The frequency of asymptomatic atopy and relationship to latent tuberculosis in health workers

YILMAZ İ., Akcay S., Tusrkkan O., Bozkurt B.

ASTIM ALLERJI IMMUNOLOJI , cilt.11, sa.1, ss.43-48, 2013 (ESCI, TRDizin) Sürdürülebilir Kalkınma

140. Idiopathic anaphylaxis: hereditary angioedema in the differential diagnosis

YILMAZ İ., TUTAR N., Buyukoglan H., GÜLMEZ İ., Oymak S., Demir R.

ASTIM ALLERJI IMMUNOLOJI , cilt.11, sa.1, ss.53-58, 2013 (ESCI, TRDizin)

141. Late onset anaphylaxis in a hydatid cyst case presenting with chronic urticaria

YILMAZ İ., Aydin O., Okoh A., Misirligil Z.

Case Reports in Medicine , cilt.2013, 2013 (SCI-Expanded, Scopus)

142. Biphasic anaphylaxis to gemifloxacin

YILMAZ İ., Dogan S., TUTAR N., Kanbay A., Buyukoglan H., Demir R.

ASIA PACIFIC ALLERGY , cilt.2, sa.4, ss.280-282, 2012 (ESCI)

143. Asthma control test administered by web-based text messaging (short message service-SMS): Is it comparable with paper form?

Uysal M. A., Mungan D., Yorgancioglu A., Yildiz F., AKGÜN M., GEMİCİOĞLU B., et al.

EUROPEAN RESPIRATORY JOURNAL , cilt.40, 2012 (SCI-Expanded, Scopus)

144. Prevalence of aspirin-exacerbated respiratory disease in patients with asthma in Turkey: A cross-sectional survey

Bavbek S., Yilmaz I., Celik G., Aydin O., Erkekol F. O., Orman A., et al.

ALLERGOLOGIA ET IMMUNOPATHOLOGIA , cilt.40, sa.4, ss.225-230, 2012 (SCI-Expanded, Scopus)

145. Self-Reported Knowledge and Approaches Toward Complementary and Alternative Medicine Among Physicians Dealing with Allergic Diseases

ARGUDER E., Yilmaz I., Ates C., Misirligil Z., Bavbek S.

AMERICAN JOURNAL OF CHINESE MEDICINE , cilt.40, sa.4, ss.671-683, 2012 (SCI-Expanded, Scopus)

146. Pyrazinamide-Induced Anaphylaxis: Diagnosed by Skin Test and Successful Desensitization

Bavbek S., Yilmaz I., Aydin O., Ozdemir S. K.

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY , cilt.157, sa.2, ss.209-212, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

147. Therapy with omalizumab in patients with severe persistant allergic asthma: A real life data in Turkey Aǧir allerjik astimli hastalarda anti-IgE (omalizumab) tedavisi: Gerçek yaşam verileri

Bavbek S., Aydin Ö., Kepil Özdemir S., YILMAZ İ., Çelik G. E., Demirel Y. S., et al.

Tuberkuloz ve Toraks , cilt.58, sa.4, ss.425-434, 2010 (SCI-Expanded, Scopus, TRDizin)

148. Therapy with omalizumab in patients with severe persistant allergic asthma: a real life data in Turkey

BAVBEK S., AYDIN Ö., Ozdemir S. K., YILMAZ İ., ÇELİK G. E., DEMİREL Y. S., et al.

TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX , cilt.58, sa.4, ss.425-434, 2010 (ESCI, Scopus, TRDizin)

149. Attitudes and Knowledge for Smoking Among University Students

Akcay S., Dilektasli A. G., Budakoglu I., Yilmaz I., Erdem O.

TURKIYE KLINIKLERI TIP BILIMLERI DERGISI , cilt.29, sa.3, ss.611-617, 2009 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

150. Fire-eater's pneumonia after aspiration of liquid paraffin

Turkish Journal of Pediatrics , cilt.48, sa.1, ss.85-88, 2006 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 57

1. Kronik Rinosinüzit/Nazal Polipli Geç Başlangıçlı Eozinofilik Astımın T Hücre İmmün Fenotipleri, Periostin ve Fibrinolitik Sistem ile İlişkisi

Taheri S., Yılmaz İ., Eken A., Erdem Ş., Paçacı Çetin G., Arslan B., et al.

29. Ulusal Allerji ve Klinik İmmünoloji Kongresi, Antalya, Türkiye, 29 Kasım - 03 Aralık 2023, (Özet Bildiri)

2. Covid-19 hastalığı ağırlığını belirlemede inflamatuar biyomarkerların yeri

BARAN B., KARAAĞAÇ F., YETKİN N. A., TUTAR N., GÜLMEZ İ., OYMAK F. S., et al.

Türk Toraks Derneği 26.Yıllık Ulusal Kongresi, Antalya, Türkiye, 9 - 13 Mayıs 2023, (Özet Bildiri)

3. Ankilozan Spondilit Hastalarında Obstrüktif Uyku Apnesi Sıklığı

GULIYEVA A., TUTAR N., GÜLMEZ İ., OYMAK F. S., YILMAZ İ., BARAN B., et al.

Uluslararası Katılımlı Akciğer Sağlığı Kongresi, Antalya, Türkiye, 15 - 18 Mart 2023, (Özet Bildiri)

4. Friedreich Ataksili Bireylerde Diyaframın Ultrasonografik Değerlendirilmesi Ve Solunum Fonksiyon Testleri Ile Korelasyonu

Yetkin N. A., Yetkin M. F., Baran Ketencioğlu B., Gülmez İ., Yılmaz İ., Oymak F. S., et al.

Uluslararası Katılımlı Ulusal Akciğer Sağlığı Kongresi, Antalya, Türkiye, 15 - 18 Mart 2023, ss.49, (Özet Bildiri)

5. KOAH Hastalarında OSA Sıklığı-Overlap Sendrom: Kliniğimizin 10 Yıllık Verileri

Yetkin N. A., Almadqa M. T., Baran Ketencioğlu B., Oymak F. S., Yılmaz İ., Gülmez İ., et al.

Uluslararası Katılımlı Ulusal Akciğer Sağlığı Kongresi, Antalya, Türkiye, 15 - 18 Mart 2023, ss.185, (Özet Bildiri)

6. Stabil Dönemdeki Bronşektazi Hastalarında İnflamasyon Markerlerinin Değerlendirilmesi, Kliniğimizden 5 Yıllık Hasta Verileri

YİĞİT F., BARAN KETENCİOĞLU B., YETKİN N. A., TUTAR N., GÜLMEZ İ., YILMAZ İ., et al.

Türk Toraks Derneği 25. Yıllık Kongresi, Antalya, Türkiye, 24 Mayıs 2022, (Özet Bildiri)

7. Capsaicin pretreatment increases IgE-mediated but not histamine-induced wheal and erythema responses: a proof of concept study

TÜRK M., YILMAZ İ., NAZİK BAHÇECİOĞLU S., paçacı çetin g., TUTAR N., BARAN KETENCİOĞLU B., et al.

5th GA2LEN Global Urticaria Forum, Berlin, Almanya, 1 - 02 Aralık 2020, (Özet Bildiri)

8. False positive PET CT in non-malignant pulmonary lesions

TUTAR N., Yenigün S., OYMAK F. S., YILMAZ İ., GÜLMEZ İ.

Imaging, 28 Eylül - 02 Ekim 2019, (Özet Bildiri)

9. What should the ideal adrenaline auto-injector needle length be?

TÜRK M., Turk G., Koc A., Karabiyik Ö., YILMAZ İ.

Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Lisbon, Portekiz, 1 - 05 Haziran 2019, cilt.74, ss.144-145, (Özet Bildiri)

10. Worsening of chronic spontaneous urticaria after intake of hot pepper

Turk M., YILMAZ İ., Maurer M.

Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Lisbon, Portekiz, 1 - 05 Haziran 2019, cilt.74, ss.612-613, (Özet Bildiri)

11. Astım hastalarında fiziksel aktivite ve beslenme tutum ve davranışların belirlenmesi ve astım kontrolü ile ilişkisinin değerlendirilmesi: ulusal çok merkezli bir araştırma verileri

AYDIN Ö., ÇELEBİ SÖZENER Z., MUNGAN V. D., yıldız F., BARIŞ S., GEMİCİOĞLU B., et al.

Türk Toraks Derneği 22. Ulusal Kongresi, Türkiye, 10 - 14 Nisan 2019, (Özet Bildiri)

12. ASTIM HASTALARINDA FIZIKSEL AKTIVITEVE BESLENME TUTUM VE DAVRANIŞLARINBELIRLENMESI VE ASTIM KONTROLÜ ILEILIŞKISININ DEĞERLENDIRILMESI: ULUSAL ÇOKMERKEZLI BIR ARAŞTIRMA VERILERI

AYDIN Ö., ÇELEBİ SÖZENER Z., MUNGAN V. D., Yıldız F., ARGUN BARIŞ S., GEMİCİOĞLU B., et al.

TÜRK TORAKS DERNEĞİ ULUSLARARASI KATILIMLI 22. YILLIK KONGRESİ, Antalya, Türkiye, 10 - 14 Nisan 2019, ss.90, (Özet Bildiri)

13. Astım hastalarında fiziksel aktivite ve beslenme tutum ve davranışların belirlenmesi ve astım kontrolü ile ilişkisinin değerlendirilmesi: Ulusal çok merkezli bir araştırma verileri

AYDIN Ö., ÇELEBİ SÖZENER Z., MUNGAN V. D., YILDIZ F., ARGUN BARIŞ S., GEMİCİOĞLU B., et al.

Türk Toraks Derneği 22. Yıllık Kongresi, 10 - 14 Nisan 2019, (Tam Metin Bildiri)

14. How to discontinue omalizumab in chronic spontaneous urticaria?

TÜRK M., maurer m., YILMAZ İ.

Global Urticaria Forum, Berlin, Almanya, 5 - 06 Aralık 2018, (Tam Metin Bildiri)

15. Exacebation of chronic spontaneous urticaria after intake of hot pepper

TÜRK M., YILMAZ İ., maurer m.

Global Urticaria Forum, Berlin, Almanya, 5 - 06 Aralık 2018, (Tam Metin Bildiri)

16. Kronik spontan ürtikerde omalizumab tedavisinin sonlandırılması: Gerçek yaşam deneyimi

TÜRK M., maurer m., YILMAZ İ.

25. ulusal allerji immünoloji kongresi, Antalya, Türkiye, 17 - 21 Kasım 2018, (Özet Bildiri)

17. Adrenalin otoenjektor iğne uzunluğu erişkin hastalar için yeterli midir?

TÜRK M., türk g., koç a., KARABIYIK Ö., YILMAZ İ.

25 yıllık allerji immünoloji kongresi, Antalya, Türkiye, 17 - 21 Kasım 2018, (Tam Metin Bildiri)

18. Acı biber tüketimi kronik spontan ürtikerli hastalarda semptom kontrolünü bozar mı?

TÜRK M., YILMAZ İ., maurer m.

25. ulusal allerji immünoloji kongresi, Antalya, Türkiye, 17 - 21 Kasım 2018, (Özet Bildiri)

19. Omalizumab tedavi aralığının sonlarına doğru semptom artışı olan hastalarda, ürtiker kontrol testi hastalık kontrolünü yanlış değerlendiriyor olabilir mi?

TÜRK M., YILMAZ İ.

25. ıllık ulusal allerji immünolji kongresi, 17 - 21 Kasım 2018, (Tam Metin Bildiri)

20. ADRENALİN OTOENJEKTÖR İĞNE UZUNLUĞU ERİŞKİN HASTALAR İÇİN YETERLİ MİDİR?

TÜRK M., TÜRK G., KOÇ A., KARABIYIK Ö., YILMAZ İ.

25. ULUSAL ALERJİ VE KLİNİK İMMÜNOLOJİ KONGRESİ, Türkiye, 17 - 21 Kasım 2018, (Özet Bildiri)

21. THE ASSOCIATION OF BRAIN-DERIVED NEUROTROPHIC FACTOR GENE POLYMORPHISM WITH OBSTRUCTIVE SLEEP APNEA SYNDROME and OBESITY

TUTAR N., yüksekkaya m., DÜNDAR M., YILMAZ İ., GÜLMEZ İ., OYMAK F. S., et al.

european respiratory society congress 2018, 15 - 19 Eylül 2018, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

22. Omalizumab treatment in atopic severe persistent asthma: A single center long-term real-life experience with thirty eight patients

TÜRK M., Bahcecioglu N. S., TUTAR N., OYMAK F. S., GÜLMEZ İ., YILMAZ İ.

Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Munich, Almanya, 26 - 30 Mayıs 2018, ss.672, (Özet Bildiri)

23. Last station in the eosinophilic asthmawith chronic rhinosinusitis and or nasal polyposismarch: Eosinophilic asthma with radiologicalfindings associated with blood eosinophilia

YILMAZ İ., NAZİK BAHÇECİOĞLU S., TÜRK M., TUTAR N., OYMAK F. S., GÜLMEZ İ.

EAACI Annual Congress 2018, Munich, Almanya, 26 - 30 Mayıs 2018, cilt.73, (Özet Bildiri)

24. Ranitidine-Induced Anaphylaxis in a Patient with Acute COPD Exacerbation

Türk Toraks Derneği Yıllık Kongresi 2018, 11 - 15 Nisan 2018, cilt.19, (Özet Bildiri)

25. Last Station in the Eosinophilic Asthma with Chronic Rhinosinusitis and/or Nasal Polyposis March: Eosinophilic Asthma with Thorax CT Findings Associated with Blood Eosinophilia

YILMAZ İ., NAZİK BAHÇECİOĞLU S., TÜRK M., TUTAR N., OYMAK F. S., GÜLMEZ İ.

Türk Toraks Derneği Yıllık KOngresi 2018, 11 - 15 Nisan 2018, cilt.19, (Tam Metin Bildiri)

26. Omalizumab Treatment in Atopic Severe Persistant Asthma: a Single Center Real-Life Experience with Thirty Eight Patients

TÜRK M., NAZİK BAHÇECİOĞLU S., TUTAR N., OYMAK F. S., GÜLMEZ İ., YILMAZ İ.

Türk Toraks Derneği Yıllık Kongresi 2018, 11 - 15 Nisan 2018, cilt.19, (Özet Bildiri)

27. vücut kitle indeksinden bağımsız olarak akut pulmoner tromboembolisi olan ve olmayan hastalarda serum visfatin seviyesinin karşılaştırılması

TUTAR N., doğan s., yetkin N. A., şen a., YILMAZ İ., DOĞAN A., et al.

uask 2018, Türkiye, 14 - 18 Mart 2018, (Özet Bildiri)

28. organize pnömoni yanlış pozitifliği saptanan olgular

dirim n., TUTAR N., YILMAZ İ., OYMAK F. S., GÜLMEZ İ.

uask2018, Türkiye, 14 - 18 Mart 2018, (Özet Bildiri)

29. Proton pompa inhibitörlerine bağlı erken tip aşırı duyarlılık reaksiyonlarında tanısal deri testi pozitifliği ile ilişkili faktörlerin analizi.

KEPİL ÖZDEMİR S., GELİNCİK A., ÖNER ERKEKOL F., KARAKAYA G., DURSUN A. B., YILMAZ İ., et al.

XIV. Ulusal Allerji ve Klinik İmmunoloji Kongresi, Türkiye, 18 - 22 Kasım 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

30. Proton pompa inhibitörlerine bağlı erken tip aşırı duyarlılık reaksiyonlarında tanısal deri testi pozitifliği ile ilişkili faktörlerin analizi. (P-029)

KEPİL ÖZDEMİR S., GELİNCİK A., ÖNER ERKEKOL F., KARAKAYA G., DURSUN A. B., YILMAZ İ., et al.

24. Ulusal Allerji ve Klinik Immunoloji Kongresi, Antalya, Türkiye, 18 - 22 Kasım 2017, ss.29, (Özet Bildiri) Sürdürülebilir Kalkınma

31. The protective effects of thymoquinone on lung damage developed by cigarette smoke

yetkin N. A., BÜYÜKOĞLAN H., sönmez m. f., TUTAR N., YILMAZ İ., GÜLMEZ İ.

European-Respiratory-Society (ERS) International Congress, Milan, İtalya, 9 - 13 Eylül 2017, cilt.50, (Özet Bildiri)

32. Successful Desensitization in a Patient with Hypersensitivity Reaction to Laronidase

YILMAZ İ., SEZGİN ÇAĞLAR A., KARDAŞ F., ÖZDAMAR KARACA Z. C., yenigün s., TUTAR N.

Congress of the European-Academy-of-Allergy-and-Clinical-Immunology, 17 - 21 Haziran 2017, (Özet Bildiri)

33. A patient worsening with acute COPD exacerbation treatment

Congress of the European-Academy-of-Allergy-and-Clinical-Immunology, Helsinki, Finlandiya, 17 - 21 Haziran 2017, cilt.72, ss.460, (Özet Bildiri)

34. A patient worsening with acute COPDexacerbation treatment

TÜRK M., YILMAZ İ., NAZİK BAHÇECİOĞLU S.

EAACI Congress 2017, 17 - 21 Haziran 2017, (Tam Metin Bildiri)

35. Do patients who develop cough after initiation of angiotensin converting enzyme inhibitors have Asthma?

YILMAZ İ., Baran K. B., ÇETİNKAYA Z., TUTAR N., GÜLMEZ İ., OYMAK F. S., et al.

Congress of the European-Academy-of-Allergy-and-Clinical-Immunology, Helsinki, Finlandiya, 17 - 21 Haziran 2017, cilt.72, ss.381-382, (Özet Bildiri)

36. Treatment and retreatment withomalizumab in chronic spontaneous urticaria:real life experience with twenty-five patients

EAACI Congress 2017, 17 - 21 Haziran 2017, (Tam Metin Bildiri)

37. Who admitted for testing with local anesthetics and who should be tested

YILMAZ İ., AYDIN Ö., KEPİL ÖZDEMİR S., ÇELİK G. E.

Avrupa Allerji Kongresi, 11 - 15 Haziran 2016

38. Malignite Dışı Akciğer Lezyonlarında PET BT Yanlış Pozitifliği.

TAŞAN S., OYMAK F. S., TUTAR N., GÜLMEZ İ., BÜYÜKOĞLAN H., YILMAZ İ., et al.

Toraks Derneği 19. Yıllık Kongresi, Antalya, Türkiye, 6 - 10 Nisan 2016, (Özet Bildiri)

39. The comparison of serum visfatin levels in patients with acute PTE and non PTE independent of BMI

TUTAR N., doğan s., BÜYÜKOĞLAN H., şen a., YILMAZ İ., YILDIRIM A., et al.

ers international congress, 3 - 07 Ekim 2015

40. Evaluation of drug provocation test related anxiety and possible related factors caused in patients with drug hypersensitivity

SOYYİĞİT Ş., AYDIN Ö., YILMAZ İ., ÖZDEMİR S., Cankorur V. S., Atbasoglu C., et al.

Congress of the European-Academy-of-Allergy-and-Clinical-Immunology, Barcelona, İspanya, 6 - 10 Haziran 2015, cilt.70, ss.269, (Özet Bildiri)

41. Turkish version of the drug hypersensitivity quality of life questionnaire: assessment of reliability and validity

BAVBEK S., Ozdemir K. S., Erdogan D. B., Karaboga I., Buyukozturk S., GELİNCİK A., et al.

Congress of the European-Academy-of-Allergy-and-Clinical-Immunology, Barcelona, İspanya, 6 - 10 Haziran 2015, cilt.70, ss.249-250, (Özet Bildiri)

42. Response of complex undefined hypereosinophilic syndrome to treatment with imatinib: Churg-Strauss syndrome in the differantial diagnosis

YILMAZ I., KAYNAR L., TUTAR N., PALA Ç., CANÖZ Ö., Buyukoglan H., et al.

Congress of the European-Academy-of-Allergy-and-Clinical-Immunology, Barcelona, İspanya, 6 - 10 Haziran 2015, cilt.70, ss.396, (Özet Bildiri)

43. Response of complex undefined hypereosinophilic syndrome to treatment with imatinib Eosinophilic lung diseases in the differential diagnosis

YILMAZ İ., KAYNAR L., TUTAR N., CANÖZ Ö., BÜYÜKOĞLAN H., GÜLMEZ İ.

EAACI Congress 2015, 6 - 10 Haziran 2015

44. Eosinophilic phase of Churg Strauss syndrome or new asthma endotype

YILMAZ İ., TUTAR N., YILDIRIM A., BÜYÜKOĞLAN H., OYMAK F. S., GÜLMEZ İ., et al.

EAACI Congress 2015, 6 - 10 Haziran 2015

45. Allerjik bronkopulmoner aspergillozis (ABPA)

YILDIRIM A., DOĞAN S., ŞENOL S., YILMAZ İ., İMAMOĞLU H.

34. Ulusal Radyoloji Kongresi, Türkiye, 6 - 10 Kasım 2013, (Özet Bildiri)

46. Usefulness of skin tests for the diagnosis of immediate type hypersensitivity reactions to proton pump inhibitors

ÖZDEMİR K., YILMAZ İ., AYDIN Ö., Buyukozturk S., GELİNCİK A., Demirturk M., et al.

World Allergy and Asthma Congress of the European-Academy-of-Allergy-and-Clinical-Immunology and World-Allergy-Organization, Milan, İtalya, 22 - 26 Haziran 2013, cilt.68, ss.28, (Özet Bildiri)

47. Biphasic anaphylaxis to gemifloxacin

YILMAZ I., DOĞAN S., TUTAR N., KANBAY A., Buyukoglan H., DEMIR R.

World Allergy and Asthma Congress of the European-Academy-of-Allergy-and-Clinical-Immunology and World-Allergy-Organization, Milan, İtalya, 22 - 26 Haziran 2013, cilt.68, ss.217, (Özet Bildiri)

48. Learning curve of conventional transbronchial needle aspiration

TUTAR N., BÜYÜKOĞLAN H., YILMAZ İ., KANBAY A., ÖNAL Ö., BİLGİN M., et al.

2nd European Congress for Bronchology and Interventional Pulmonology., İzmir, Türkiye, 27 - 30 Nisan 2013, (Özet Bildiri)

49. Does drug compliance change in asthmatic patients during pregnancy?

YILMAZ İ., Erkekol O. F., Celen S., Karaca Z. M., AYDIN Ö., ÇELİK G., et al.

30th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), İstanbul, Türkiye, 11 - 15 Haziran 2011, cilt.66, ss.580, (Özet Bildiri)

50. Anaphylaxis to pyrazinamide: skin test positivity and successful desensitisation

BAVBEK S., YILMAZ İ., AYDIN Ö., ÖZDEMİR K.

30th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), İstanbul, Türkiye, 11 - 15 Haziran 2011, cilt.66, ss.598, (Özet Bildiri)

51. Vascular endothelial growth factor and Endostatin levels in induced sputum, and their relationship to bronchial hyperreactivity in patients with perennial allergic rhinitis

YILMAZ İ., Bayraktar N., CEYHAN K., Secil D., YÜKSEL S., DEMİREL Y. S., et al.

30th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), İstanbul, Türkiye, 11 - 15 Haziran 2011, cilt.66, ss.692-693, (Özet Bildiri)

52. Atopy and workplace related symptoms among pet shop workers

YILMAZ İ., Erkekol O. F., Kazimova A., HARMANCI K., Misirligil Z., Mungan D.

30th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), İstanbul, Türkiye, 11 - 15 Haziran 2011, cilt.66, ss.695, (Özet Bildiri)

53. Turkish physicians dealing with allergic diseases: their knowledge about complementary and alternative medicine, and attitudes towards complementary and alternative medicine

Arguder E., YILMAZ İ., Ates C., Misirligil Z., BAVBEK S.

30th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), İstanbul, Türkiye, 11 - 15 Haziran 2011, ss.641, (Özet Bildiri)

54. Therapy with omalizumab in patients with severe persistant allergic asthma: real life data in Turkey

BAVBEK S., AYDIN Ö., ÖZDEMİR K., YILMAZ İ., ÇELİK G., DEMİREL Y. S., et al.

30th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), İstanbul, Türkiye, 11 - 15 Haziran 2011, cilt.66, ss.366, (Özet Bildiri)

55. Triggers of COPD: Are they different from asthma?

AYDIN Ö., ÇELİK G., ÖNEN Z. P., YILMAZ İ., ÖZDEMİR S., YILDIZ Ö., et al.

30th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), İstanbul, Türkiye, 11 - 15 Haziran 2011, cilt.66, ss.368, (Özet Bildiri)

56. Evaluation of vascular remodeling in induced sputum and relationship to bronchial hyperreactivity in patients with seasonal allergic rhinitis

YILMAZ İ., Secil D., YÜKSEL S., Misirligil Z., DEMİREL Y. S., BAVBEK S.

29th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), London, Kanada, 5 - 09 Haziran 2010, cilt.65, ss.725, (Özet Bildiri)

57. The relationship between conventional and tissue Doppler echocardiographic findings and plasma N-Terminal pro Brain Natriuretic Peptide levels in hypertensive patients with left ventricular diastolic

Ceyhan C., ÜNAL S., Tekten T., Yenisey C., YILMAZ İ.

28th Congress of the European-Society-of-Cardiology/World Congress of Cardiology, Barcelona, İspanya, 2 - 06 Eylül 2006, ss.980, (Özet Bildiri)

Kitaplar 25

1. Astımın Kronik Tedavisi - Basamak Tedavisi 2022 Güncellemesi

Paçacı Çetin G., Yılmaz İ.

Astımın Kronik Tedavisi - Basamak Tedavisi 2022 Güncellemesi, Prof. Dr. Gülfem E. ÇELİK, Editör, BULUŞ Tasarım ve Matbaacılık , Ankara, ss.1-38, 2022

2. COVID-19 Aşıları ile İlişkili Anafilaksi ve Alerjik Reaksiyonlar

Arslan B., Yılmaz İ.

COVID-19 ve Allerjik Hastalıklar , Şadan Soyyiğit, Editör, Türkiye Klinikleri Yayınevi, Ankara, ss.19-26, 2022 Sürdürülebilir Kalkınma

3. BRONKOPROVOKASYON TESTLERİNİN KLİNİK KULLANIMI

Solunum Fonksiyon Testleri: Klinik Uygulamalar, Sevgi Saryal,Öznur Yıldız, Editör, Türkiye Klinikleri Yayınevi, Ankara, ss.28-34, 2022

4. Anafilaksi

Paçacı Çetin G., Yılmaz İ.

Güncel Klavuzlar Eşliğinde İç Hastalıkları , Aydın Çiftci, Editör, Hipokrat , Ankara, ss.2728-2733, 2022

5. ALERJİK RİNİT ENDOTİPLERİ VE FENOTİPLERİ .........

ÇELİK G. E., YILMAZ İ., ARTAÇ H.

Alerjik Rinit Tanı ve Tedavi Rehberi 2022, Kalpaklıoğlu F, Demirel YS, Editör, BULUŞ Tasarım ve Matbaacılık Hizmetleri, Ankara, ss.38-47, 2022

6. Ağır Astım ve Biyolojik Tedaviler

Paçacı Çetin G., Yılmaz İ.

Dünya Tıp Kitabevi, Ankara, 2021

7. Egzersize bağlı bronkokonstriksiyon: patogenezden tanı yöntemlerine

Sporcularda Alerjik Hastalıklar, Adile Berna Dursun, Editör, Türkiye Klinikleri Yayınevi, Ankara, ss.11-21, 2021

8. Bronş Provokasyon Testleri

GÖĞÜS HASTALIKLARI TANI ve TEDAVİ EL KİTABI, Prof. Dr. Mehmet Karadağ Prof. Dr. Akın Kaya Prof. Dr. Tevfik Özlü, Editör, BİLİMSEL TIP YAYINEVİ, Ankara, ss.82-89, 2021

9. ZOR ASTIM